Abeona Therapeutics Inc (ABEO) Stock Price Today
Key Stats
- $341.67MMarket Cap
- -Volume
- HealthSector
- $7.4652W High
- $4.1752W Low
- -Typical Hold Time
- $214.72MEnterprise Value
- -Div Yield
- -Trading Activity
Track Abeona Therapeutics Inc (ABEO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Abeona Therapeutics Inc has traded between a low of $4.17 and a high of $7.46, highlighting its annual price range. Buy and sell Abeona Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Most Recent News
Nvidia-based ETF outperforms Tesla-based ETF by 30% due to underlying stock trends in option-income strategy.
The YieldMax NVDA Option Income Strategy ETF (NVDY) and the YieldMax TSLA Option Income Strategy ETF (TSLY) use the same call-writing strategy but differ only in their underlying stocks, Nvidia and Tesla respectively. Over the past eight months, NVDY...

Micron plans to boost stock buybacks after Dec 9, 2026, when CHIPS Act restrictions expire.
Micron Technology's CEO Sanjay Mehrotra confirmed the company will increase stock buybacks starting December 9, 2026, the second anniversary of its CHIPS Act funding agreement, which currently restricts large-scale buybacks. While competitors like SK...

Bayer pays first milestone to MustGrow for biocontrol tech in EMEA under 2023 deal
MustGrow Biologics has received the first milestone payment from Bayer AG under their December 2023 License and Collaboration Agreement. The deal grants Bayer rights to MustGrow's mustard-based biocontrol technologies for soil applications in Europe,...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.